Seres therapeutics to present clinical research on the microbiome's impact on allogeneic hematopoietic stem cell transplantation and cancer immunotherapy at the 2021 american society of clinical oncology (asco) annual meeting

Cambridge, mass.--(business wire)--seres therapeutics, inc. (nasdaq: mcrb), a leading microbiome therapeutics company, announced today that it will present the latest research from its early stage clinical development programs in two presentations at the american society of clinical oncology (asco) annual meeting, taking place virtually from june 4-8, 2021. in an oral presentation, seres will share data from its collaboration with the university of cologne (kÖln, germany) assessing the associat
MCRB Ratings Summary
MCRB Quant Ranking